You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

L-glutamine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for l-glutamine and what is the scope of patent protection?

L-glutamine is the generic ingredient in three branded drugs marketed by Emmaus Medcl and Novitium Pharma, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-five drug master file entries for l-glutamine. Two suppliers are listed for this compound.

Summary for l-glutamine
US Patents:0
Tradenames:3
Applicants:2
NDAs:3
Drug Master File Entries: 45
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 188
Clinical Trials: 185
Patent Applications: 7,008
What excipients (inactive ingredients) are in l-glutamine?l-glutamine excipients list
DailyMed Link:l-glutamine at DailyMed
Recent Clinical Trials for l-glutamine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of New MexicoPhase 4
Anahuac UniversityN/A
David J. CangemiPhase 1/Phase 2

See all l-glutamine clinical trials

Pharmacology for l-glutamine
Drug ClassAmino Acid

US Patents and Regulatory Information for l-glutamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emmaus Medcl ENDARI l-glutamine FOR SOLUTION;ORAL 208587-001 Jul 7, 2017 AA RX Yes No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Emmaus Medcl NUTRESTORE l-glutamine FOR SOLUTION;ORAL 021667-001 Jun 10, 2004 DISCN Yes No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Novitium Pharma L-GLUTAMINE l-glutamine FOR SOLUTION;ORAL 215647-001 Jul 8, 2024 AA RX No No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for L-Glutamine

Introduction

L-Glutamine, an essential amino acid, has been gaining significant attention in various industries, including healthcare, pharmaceuticals, and sports nutrition. This article delves into the market dynamics and financial trajectory of L-Glutamine, highlighting its current status, growth prospects, and key drivers.

Market Size and Growth

The global L-Glutamine market is experiencing steady growth, driven by increasing demand from health-conscious consumers and the expanding use in medical settings.

  • As of 2022, the glutamine market was valued at USD 130 million and is estimated to expand at a CAGR of 3.4% between 2023 and 2032, reaching USD 182.3 million by 2032[3].
  • Another report indicates that the global glutamine market was valued at USD 131.20 million in 2023 and is expected to reach USD 178.81 million by 2032, growing at a CAGR of 3.5% during the forecast period[5].

Segmentation and Dominant Segments

The L-Glutamine market is segmented based on type, form, and application.

Type

  • The L-Glutamine segment dominates the market, accounting for a significant share due to its widespread use and health benefits. L-Glutamine holds a value share of 63% in 2023 and is expected to continue its dominance[4].

Form

  • The powder form of L-Glutamine is the most popular, accounting for 55% to 58% of the market share. This is due to its versatility, cost-effectiveness, and extended shelf life[3][4].

Application

  • The dietary supplements segment is a major driver, with L-Glutamine being used to support immune health, gut health, and muscle recovery. This segment is expected to gain remarkable momentum during the forecast period[3].

Regional Analysis

The demand for L-Glutamine varies significantly across different regions.

North America

  • North America, particularly the United States, is a highly remunerative market for L-Glutamine. The region's well-established healthcare infrastructure and large consumer base focused on health and wellness drive this demand. The U.S. market is projected to grow at a CAGR of 3.9% during the forecast period[4][5].

Asia-Pacific

  • The Asia-Pacific region is the fastest-growing market for L-Glutamine, driven by rising disposable incomes, increasing health awareness, and a burgeoning nutraceutical industry. Countries like India and China are seeing significant growth in the demand for L-Glutamine-based products[5].

Key Drivers

Several factors are driving the growth of the L-Glutamine market.

Health and Wellness Trends

  • The increasing focus on overall health and wellness among consumers is a major driver. L-Glutamine is recognized for its role in supporting gut health, immune function, and muscle recovery, aligning with these trends[3][4].

Medical Applications

  • L-Glutamine is used in medical settings for various purposes, including as a supplement for critically ill patients, to support wound healing, and to address certain gastrointestinal conditions. This medical use further boosts the market[3].

Sports Nutrition

  • The growing awareness of the importance of fitness and nutrition, especially among athletes and fitness enthusiasts, is driving the demand for L-Glutamine supplements. It is believed to aid in muscle recovery and enhance performance[4].

Market Challenges

Despite the growth, the L-Glutamine market faces some challenges.

Regulatory Frameworks

  • Strict regulatory frameworks in different regions can affect the market growth. Ensuring compliance with these regulations is crucial for market players[5].

Competition

  • The market is competitive, with several key players such as Ajinomoto, Vitamin Well, Kyowa Hakko Bio, and Evonik Industries. Companies need to invest in research and development to introduce innovative products and stay ahead[3][4].

Financial Trajectory

The financial trajectory of the L-Glutamine market is promising.

  • The global L-Glutamine market is estimated to reach USD 178.81 million by 2032, growing at a CAGR of 3.5% during the forecast period[5].
  • The L-Alanyl-L-Glutamine market, a related segment, is valued at US$ 49 million in 2023 and is anticipated to reach US$ 66 million by 2030, witnessing a CAGR of 4.4% during the forecast period[1].

Key Players and Strategies

Major companies in the L-Glutamine market are adopting various strategies to maintain their market position.

  • Companies are focusing on strategic partnerships, new product launches, and commercialization. They are also investing heavily in research to introduce innovative products and garner maximum revenue[3][4].
  • Inorganic strategies such as acquisitions, partnerships, mergers, and distribution agreements are common. Targeted marketing campaigns are also being used to increase the customer base[4].

Consumer Preferences and Awareness

Consumer preferences and awareness play a crucial role in the market dynamics.

  • Consumers increasingly prefer plant-based and vegan products, leading to a growing interest in L-Glutamine sourced from plant proteins. This trend is expected to continue, driving the market forward[3].
  • A study by the Food Safety and Standards Authority of India (FSSAI) revealed that 62% of urban Indian consumers were aware of the health benefits of amino acid supplements like L-Glutamine, indicating a high level of consumer awareness[5].

Online and Offline Distribution

The distribution channels for L-Glutamine are evolving.

  • The market is segmented into offline retail and online retail. The online dietary supplement market is projected to reach USD 8.2 billion by 2027 in the Asia-Pacific region, providing substantial opportunities for L-Glutamine product sales[5].

Conclusion

The L-Glutamine market is poised for significant growth driven by its health benefits, increasing consumer awareness, and expanding medical applications. As the market continues to evolve, key players will need to focus on innovation, quality, and transparency to maintain their market share.

Key Takeaways

  • The global L-Glutamine market is expected to grow at a CAGR of 3.4% to 3.5% between 2023 and 2032.
  • The L-Glutamine segment dominates the market due to its widespread use and health benefits.
  • North America and the Asia-Pacific region are key markets, driven by health and wellness trends and medical applications.
  • Consumer preference for plant-based and vegan products is on the rise.
  • Major companies are investing in research and development and adopting inorganic strategies to stay competitive.

FAQs

What is the current market size of the L-Glutamine market?

The global L-Glutamine market was valued at USD 130 million in 2022 and USD 131.20 million in 2023[3][5].

What is the expected growth rate of the L-Glutamine market?

The market is expected to grow at a CAGR of 3.4% to 3.5% between 2023 and 2032[3][5].

Which segment dominates the L-Glutamine market?

The L-Glutamine segment dominates the market, accounting for a value share of 63% in 2023[4].

What are the primary applications of L-Glutamine?

L-Glutamine is primarily used in dietary supplements, pharmaceuticals, sports nutrition, and clinical nutrition[3][4].

Which regions are driving the growth of the L-Glutamine market?

North America and the Asia-Pacific region are the key drivers, with the latter being the fastest-growing market[4][5].

Sources

  1. Global L-Alanyl-L-Glutamine Market Research Report 2024 - Valuates Reports
  2. Global L-Glutamine Supplement Market to Witness Unprecedented Growth 2024-2032 - Wicz
  3. Glutamine Market Size & Share | Growth Outlook 2023-2032 - GMI Insights
  4. Glutamine Market Size, Share, Trends & Forecast by 2034 - Future Market Insights
  5. Glutamine Market Size to Rise US$178.81 million by 2032 - Straits Research

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.